Companies: 10,795·Total market cap: $144.5T
4D Molecular Therapeutics, Inc.

4D Molecular Therapeutics, Inc.

FDMTNASDAQHealthcare● Active
$8.64
$-1.37(-13.69%)
Market Cap$451666835
P/E Ratio
52W High$12.34
52W Low$3.68

4D Molecular Therapeutics, Inc. (FDMT) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · FDMT · as of Mar 18, 2026

Latest filing snapshot

196
-31-13.66%vs prior year

4D Molecular Therapeutics, Inc. (FDMT) employee data is sourced from the annual SEC 10-K filing. As of 2025, full-time employees only. Global consolidated headcount. View SEC filing

SEC 10-K·Period end: 2025-12-31·Full-time · Global
Total Employees
196
Change (1Y)
-31
Growth % (1Y)
-13.66%
Revenue / Employee
$434.7K
Net Income / Employee
$-714.8K
Market Cap
$452M

FDMT Employee Count

2020 – 2025 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing DateEmployeesChange (1Y)Growth (1Y)SEC filing link
2026-03-18196-31-13.66%
2025-02-28227+80+54.42%
2024-02-29147+7+5.00%
2023-03-15140+16+12.90%
2022-03-28124+41+49.40%
2021-03-2583

Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Biotechnology
#SymbolCompanyEmployees
#1
Bicycle Therapeutics plc
BCYC
Bicycle Therapeutics plc
305
#2
ADC Therapeutics S.A.
ADCT
ADC Therapeutics S.A.
263
#3
4D Molecular Therapeutics, Inc.
FDMT
4D Molecular Therapeutics, Inc.YOU
196
#4
KalVista Pharmaceuticals, Inc.
KALV
KalVista Pharmaceuticals, Inc.
150
#5
Gossamer Bio, Inc.
GOSS
Gossamer Bio, Inc.
144
#6
Lexicon Pharmaceuticals, Inc.
LXRX
Lexicon Pharmaceuticals, Inc.
103
#7
Compass Therapeutics, Inc.
CMPX
Compass Therapeutics, Inc.
35
Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · FDMT peer comparison

About FDMT employees

FDMT Employees · Headcount

4D Molecular Therapeutics, Inc. (FDMT) employee data is sourced from the annual SEC 10-K filing. As of 2025, 4D Molecular Therapeutics, Inc. had 196 full-time employees globally. Full-time employees only. Global consolidated headcount.

4D Molecular Therapeutics, Inc. employs 196 full-time employees as of the latest filing within the Biotechnology industry. Revenue per employee stands at $434,740, reflecting the company's operational efficiency.

4D Molecular Therapeutics, Inc.'s workforce decreased by 31 (13.66%) in 2025 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

4D Molecular Therapeutics, Inc.'s revenue per employee of $434,740 positions it among the notable performers in the Biotechnology sector for operational efficiency.

Frequently Asked Questions

FDMT Employees · 5 questions

As of the latest SEC 10-K filing (2025), 4D Molecular Therapeutics, Inc. had 196 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

4D Molecular Therapeutics, Inc. employee counthow many employees does 4D Molecular Therapeutics, Inc. haveFDMT total employees 2025

Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2026-03-18